SCHEMBL22769231

SCHEMBL22769231

COc1ccc(COCC#Cc2ccc(Br)cn2)cc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 3/20 0.43
TSHR P16473 1/20 0.41
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAOB P27338 2/20 0.39
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
IDO1 P14902 2/20 0.36
AGXT P21549 2/20 0.36
PDE2A O00408 1/20 0.36
APP P05067 3/20 0.36
CCR5 P51681 1/20 0.36
ACACB O00763 2/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29756638 0.77 GRM5 (0.43) GRM5NPC1RAB9AGAAMCHR1
SCHEMBL285550 0.77 GRM5 (0.43) GRM5NPC1RAB9AGAAMCHR1
SCHEMBL27138292 0.73 TSHR (0.35) TSHRNPC1RAB9AMAOBIDO1
SCHEMBL20129257 0.73 TSHR (0.35) TSHRNPC1RAB9AMAOBIDO1
SCHEMBL22769234 0.72 IDO1 (0.38) NPC1RAB9AMAOBMEN1GAA
SCHEMBL1310325 0.72 KMT2A (0.58) NPC1RAB9AMAOBMEN1GAA
SCHEMBL30659808 0.72 MAOB (0.50) TSHRNPC1RAB9AMAOBMEN1
SCHEMBL3415984 0.72 MAOB (0.50) TSHRNPC1RAB9AMAOBMEN1
SCHEMBL20120611 0.71 IDO1 (0.47) MAOBL3MBTL1IDO1AGXTAPP
SCHEMBL20213990 0.71 IDO1 (0.50) MAOBL3MBTL1IDO1AGXTAPP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021104488-A1 TRI-HETEROCYCLIC COMPOUND AS JAK INHIBITOR, AND USE THEREOF 正大天晴药业集团股份有限公司 2021-06-03 WO disclosed
WO-2020244614-A1 PYRROLOPYRIMIDINE COMPOUND AND USE THEREOF 南京明德新药研发有限公司 2020-12-10 WO disclosed